Angelo Stracquatanio
CEO & Co-Founder

Angelo is Co-founder and CEO of, the leading intelligent software provider for life sciences that allows manufacturing teams to get critical drugs to market faster, with higher reliability. Angelo has positioned Apprentice as the worldwide frontrunner of innovative technology, leveraging artificial intelligence, augmented reality and Pharma 4.0 principles to help organizations scale faster – from COVID to Cancer. Believing that technology should foster creativity and drive solution discovery, Angelo founded Apprentice to address the pharmaceutical industry’s greatest challenges. As a result, Apprentice’s flexible and intuitive intelligent software platform was developed, offering batch execution, augmented procedures, predictive resource management, immersive training, remote collaboration/troubleshooting, remote tours, event tracking and more, across one end-to-end system that unifies internal teams and streamlines collaboration with partners, CMOs and vendors. With over $40M in funding and expert solution teams located around the globe, Apprentice is committed to creating innovative solutions that help laboratory and manufacturing teams deliver lifesaving drugs, vaccines, therapies and treatments to market faster, for the people who need them the most.


Nov 10

02:15 PM - 02:40 PM

Grand Ballroom EF

The Rapid Adoption of AR in Life Sciences during Covid

Angelo Stracquatanio |